Dupilumab Targeting IL-4/IL-13 Pathway Improves RTK- and PD-1-Inhibitor-Related Cutaneous Adverse Drug Reactions.

Wang X, Tang JT, Feng Z, Jin D, Zhang C, Niu M, Liu Y, Wang W

DOI: 10.1111/sji.70151
Published: 2026 Oct
Container: Scandinavian journal of immunology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1111/sji.70151,
  title = {Dupilumab Targeting IL-4/IL-13 Pathway Improves RTK- and PD-1-Inhibitor-Related Cutaneous Adverse Drug Reactions.},
  author = {Wang X and Tang JT and Feng Z and Jin D and Zhang C and Niu M and Liu Y and Wang W},
  year = {2026},
  journal = {Scandinavian journal of immunology},
  doi = {10.1111/sji.70151},
  url = {https://doi.org/10.1111/sji.70151}
}

RIS

TY  - JOUR
TI  - Dupilumab Targeting IL-4/IL-13 Pathway Improves RTK- and PD-1-Inhibitor-Related Cutaneous Adverse Drug Reactions.
AU  - Wang X
AU  - Tang JT
AU  - Feng Z
AU  - Jin D
AU  - Zhang C
AU  - Niu M
AU  - Liu Y
AU  - Wang W
PY  - 2026
JO  - Scandinavian journal of immunology
DO  - 10.1111/sji.70151
UR  - https://doi.org/10.1111/sji.70151
ER  -

APA

X, W., JT, T., Z, F., D, J., C, Z., M, N., Y, L., & W, W. (2026). Dupilumab Targeting IL-4/IL-13 Pathway Improves RTK- and PD-1-Inhibitor-Related Cutaneous Adverse Drug Reactions.. Scandinavian journal of immunology. https://doi.org/10.1111/sji.70151

Source records

pubmed · retrieved 2026-09-26T08:53:45.922Z